Invitrogen Introduces NCODE™ Human miRNA Microarray V3
News Mar 31, 2008
Invitrogen Corporation announced the launch of the company’s NCode™ Human miRNA Microarray V3. Including new content available from the Sanger database 10.0 as well as 373 novel sequences discovered through deep sequencing, the Ncode human miRNA microarray enables sensitive and reproducible profiling of miRNAs within a sample.
With the NCode™ array, researchers have a powerful tool to profile miRNA expression patterns in a given disease or developmental state. The array is spotted with extensive controls for confidence in experimental results.
A research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring critical pharmacological patterns of antibiotic interactions, along with potential applications in screening other cell-type agents and guidance for clinical therapies.READ MORE